131
Participants
Start Date
November 30, 2006
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Entecavir
Tablets, Oral, 0.5 mg, once daily, up to 52 weeks
Local Institution, Belville
Local Institution, Goodwood
Va New York Harbor Healthcare System, New York
Westchester Digestive Disease Group, Llp, Yonkers
Local Institution, Campinas
Local Institution, Df
Albert Einstein Healthcare Network, Philadelphia
George Washington University Medical Center, Washington D.C.
Local Institution, Rio de Janeiro - Rj
Banks Hepatology Institute, Pc, College Park
Hunter Holmes Mcguire D V A M C, Richmond
Local Institution, Belo Horizonte - Mg
University Of Miami, Miami
Empire International Research, Miami
Alabama Liver & Digestive Specialists (Alds), Montgomery
Local Institution, Salvador
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Guadalajara
Local Institution, Zapopan
University Of Chicago, Chicago
Alamo Medical Research, San Antonio
University Of Arizona, Tucson
Brigham And Women'S Hospital, Boston
L L C Bda The Research Institute, Springfield
Local Institution, Sao Paulo - Sp
Local Institution, Santurce
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY